Currently, there are 1.73B common shares owned by the public and among those 1.71B shares have been available to trade.
The company’s stock has a 5-day price change of 5.28% and 5.41% over the past three months. GOLD shares are trading 15.74% year to date (YTD), with the 12-month market performance up to 26.78% higher. It has a 12-month low price of $13.76 and touched a high of $21.35 over the same period. GOLD has an average intraday trading volume of 20.92 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.33%, 9.61%, and 0.16% respectively.
Institutional ownership of Barrick Gold Corp (NYSE: GOLD) shares accounts for 62.44% of the company’s 1.73B shares outstanding.
It has a market capitalization of $30.98B and a beta (3y monthly) value of 0.59. The stock’s trailing 12-month PE ratio is 14.65, while the earnings-per-share (ttm) stands at $1.22. The company has a PEG of 1.68 and a Quick Ratio of 2.15 with the debt-to-equity ratio at 0.19. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.47% over the week and 2.92% over the month.
Analysts forecast that Barrick Gold Corp (GOLD) will achieve an EPS of 0.25 for the current quarter, 0.33 for the next quarter and 1.72 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.2 while analysts give the company a high EPS estimate of 0.2. Comparatively, EPS for the current quarter was 0.19 a year ago. Earnings per share for the fiscal year are expected to increase by 24.17%, and 7.10% over the next financial year. EPS should grow at an annualized rate of 8.74% over the next five years, compared to -11.58% over the past 5-year period.
Looking at the support for the GOLD, a number of firms have released research notes about the stock. BofA Securities stated their Neutral rating for the stock in a research note on January 27, 2025, with the firm’s price target at $21-$18. CIBC was of a view on November 25, 2024 that the stock is Neutral, while UBS gave the stock Neutral rating on October 30, 2024, issuing a price target of $23- $22. Argus on their part issued Buy rating on August 29, 2024.
